🇺🇸 FDA
Patent

US 11883381

ASH1L inhibitors and methods of treatment therewith

granted A61KA61K31/404A61K45/06

Quick answer

US patent 11883381 (ASH1L inhibitors and methods of treatment therewith) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/404, A61K45/06, A61P, A61P35/02